Hear first-hand from attendees on why the ISPE Annual Meeting & Expo is the must-attend pharmaceutical event of the year.
The 2018 ISPE Annual Meeting & Expo will focus on excellence, modernization, and harmonization in pharmaceutical science and manufacturing across the globe, offering pharma professionals the opportunity to engage in industry-critical conversations. A comprehensive education program provides attendees with technical sessions on the latest developments in:
Facilities & equipment
Product development & production systems
Quality systems & regulatory oversight
Cutting-edge industry innovations.
This signature event draws pharmaceutical and biopharmaceutical professionals at all levels of the industry from young professionals to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies. The conference offers a large exhibition hall offering the latest technologies and services for the pharmaceutical industry.
Expand your knowledge with one of five in-depth, interactive sessions on Sunday, 4 November
Site Master Planning
Data Integrity Strategy and Implementation
Descriptive Statistics for Pharma
Lifecycle Process Validation
Two Days of Dynamic Training
Take advantage of the early registration discount for each course!
Join us after the 2018 ISPE Annual Meeting & Expo for an in-depth education experience on the following topics:
Raise your level of technical knowledge through peer-reviewed non-commercial education content from recognized experts in the field
Expand your professional network throughout the conference in educational sessions, the exhibit hall, and numerous special events
Enhance your individual and company’s recognition among industry colleagues through face-to-face interaction
Who Should Attend?
Professionals at all levels of the industry from young professionals to the most senior executives, Communities of Practice, special interest groups, pharmaceutical industry equipment and services suppliers, and regulatory professionals.
Nick Leschly has served as chief bluebird since September 2010. bluebird bio (BLUE) is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer.
Lars Fruergaard Jørgensen joined Novo Nordisk in 1991 as an economist in Health Care, Economy & Planning and has over the years completed overseas postings in the Netherlands, the US and Japan. In 2004 he was appointed senior vice president for IT &
Executive Vice President and President, Pfizer Global Supply, Pfizer Inc.
Kirsten Lund-Jurgensen, Ph.D., is the Executive Vice President and President, Pfizer Global Supply (PGS). She is responsible for Pfizer’s internal and external manufacturing and supply network. Throughout her 30-year pharmaceutical industry career, s
Ambassador, Team Novo Nordisk and Health Care Policy Consultant, Team Novo Nordisk Diabetes Cycling Team
When she’s not racing her bike, Becky Furuta is caring for her two small children, working as a health care policy consultant, contributing to childhood anti-obesity campaigns, and providing pediatric vision therapy to the children near her hometown